Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.

Authors	Bradley A Schiff, Andrea B McMurphy, Samar A Jasser, Maher N Younes, Dao Doan, Orhan G Yigitbasi, Seungwon Kim, Ge Zhou, Mahitosh Mandal, Benjamin N Bekele, F Christopher Holsinger, Steven I Sherman, Sai-Ching Yeung, Adel K El-Naggar, Jeffrey N Myers
Journal	Clinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 25 Issue 15 Pg. 4862 (08 01 2019) ISSN: 1557-3265 [Electronic] United States
PMID	31371312 (Publication Type: Journal Article, Expression of Concern)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!